{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Camsirubicin",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A synthetic non-cardiotoxic analogue of the anthracycline antibiotic doxorubicin with potential antineoplastic activity. Camsirubicin intercalates DNA and impedes the activity of topoisomerase II, inducing single and double-stranded breaks in DNA; inhibiting DNA replication and/or repair, transcription, and protein synthesis; and activating tumor cell apoptosis.",
    "fdaUniiCode": "VI79RD8VNN",
    "identifier": "C78863",
    "preferredName": "Camsirubicin",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1594"
    ],
    "synonyms": [
      "5-Imino-13-deoxydoxoubicin",
      "CAMSIRUBICIN",
      "Camsirubicin",
      "GPX-150",
      "GPX150"
    ]
  }
}